278 research outputs found
Stented ureterovesical anastomosis in renal transplantation: does it influence the rate of urinary tract infections?
<p>Abstract</p> <p>Objective</p> <p>Our objective was to evaluate the impact of routine use of double-J stents on the incidence of urinary tract infection after renal transplantation.</p> <p>Methods</p> <p>We conducted a retrospective-comparative single-centre study in 310 consecutive adult deceased donor kidney recipients transplanted from 2002 to 2006. Patients were divided in two groups, with or without urinary stent implantation. To evaluate the predictive factors for UTI, donor and recipients pre- and post-transplantation data were analysed. Early urological complications and renal function within 12 months of transplantation were included as well.</p> <p>Results</p> <p>A total of 157 patients were enrolled to a stent (ST) and 153 patients to a no-stent (NST) group. The rate of urinary tract infection at three months was similar between the two groups (43.3% ST vs. 40.1% NST, p = 0.65). Of the identified pathogens Enterococcus and Escherichia coli were the most common species. In multivariate analysis neither age nor immunosuppressive agents, BMI or diabetes seemed to have influence on the rate of UTI. When compared to males, females had a significantly higher risk for UTI (54.0% vs. 33.5%).</p> <p>Conclusion</p> <p>Prophylactic stenting of the ureterovesical anastomosis does not increase the risk of urinary tract infection in the early postoperative period.</p
Postconditioning ameliorates lipid peroxidation in liver ischemia-reperfusion injury in rats
N-3 PUFA Supplementation Triggers PPAR-α Activation and PPAR-α/NF-κB Interaction: Anti-Inflammatory Implications in Liver Ischemia-Reperfusion Injury
Dietary supplementation with the n-3 polyunsaturated fatty acids (n-3 PUFA) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) to rats preconditions the liver against ischemia-reperfusion (IR) injury, with reduction of the enhanced nuclear factor-κB (NF-κB) functionality occurring in the early phase of IR injury, and recovery of IR-induced pro-inflammatory cytokine response. The aim of the present study was to test the hypothesis that liver preconditioning by n-3 PUFA is exerted through peroxisone proliferator-activated receptor α (PPAR-α) activation and interference with NF-κB activation. For this purpose we evaluated the formation of PPAR-α/NF-κBp65 complexes in relation to changes in PPAR-α activation, IκB-α phosphorylation and serum levels and expression of interleukin (IL)-1β and tumor necrosis factor (TNF)-α in a model of hepatic IR-injury (1 h of ischemia and 20 h of reperfusion) or sham laparotomy (controls) in male Sprague Dawley rats. Animals were previously supplemented for 7 days with encapsulated fish oil (General Nutrition Corp., Pittsburg, PA) or isovolumetric amounts of saline (controls). Normalization of IR-altered parameters of liver injury (serum transaminases and liver morphology) was achieved by dietary n-3 PUFA supplementation. EPA and DHA suppression of the early IR-induced NF-κB activation was paralleled by generation of PPAR-α/NF-κBp65 complexes, in concomitance with normalization of the IR-induced IκB-α phosphorylation. PPAR-α activation by n-3 PUFA was evidenced by enhancement in the expression of the PPAR-α-regulated Acyl-CoA oxidase (Acox) and Carnitine-Palmitoyl-CoA transferase I (CPT-I) genes. Consistent with these findings, normalization of IR-induced expression and serum levels of NF-κB-controlled cytokines IL-lβ and TNF-α was observed at 20 h of reperfusion. Taken together, these findings point to an antagonistic effect of PPAR-α on NF-κB-controlled transcription of pro-inflammatory mediators. This effect is associated with the formation of PPAR-α/NF-κBp65 complexes and enhanced cytosolic IκB-α stability, as major preconditioning mechanisms induced by n-3 PUFA supplementation against IR liver injury
The new and complete Belle II DEPFET pixel detector: Commissioning and previous operational experience
Measurement of the cross section in the energy range 0.62-3.50 GeV at Belle II
We report a measurement of the cross section in
the energy range from 0.62 to 3.50 GeV using an initial-state radiation
technique. We use an data sample corresponding to 191
of integrated luminosity, collected at a center-of-mass energy at or near the
resonance with the Belle II detector at the SuperKEKB
collider. Signal yields are extracted by fitting the two-photon mass
distribution in events, which involve a
decay and an energetic photon radiated from the
initial state. Signal efficiency corrections with an accuracy of 1.6% are
obtained from several control data samples. The uncertainty on the cross
section at the and resonances is dominated by the systematic
uncertainty of 2.2%. The resulting cross sections in the 0.62-1.80 GeV energy
range yield for the leading-order hadronic vacuum
polarization contribution to the muon anomalous magnetic moment. This result
differs by standard deviations from the most precise current
determination.Comment: 23 pages, 24 figures, submitted to PR
Measurement of branching fractions and direct asymmetries for and decays at Belle II
We report measurements of the branching fractions and direct
asymmetries of the decays , , , and , and use these for testing the standard
model through an isospin-based sum rule. In addition, we measure the branching
fraction and direct asymmetry of the decay and
the branching fraction of the decay . The data are
collected with the Belle II detector from collisions at the
resonance produced by the SuperKEKB asymmetric-energy collider
and contain bottom-antibottom meson pairs. Signal yields are
determined in two-dimensional fits to background-discriminating variables, and
range from 500 to 3900 decays, depending on the channel. We obtain for the sum rule, in agreement with the standard model
expectation of zero and with a precision comparable to the best existing
determinations
Precise measurement of the lifetime at Belle II
We measure the lifetime of the meson using a data sample of 207
fb collected by the Belle II experiment running at the SuperKEKB
asymmetric-energy collider. The lifetime is determined by fitting the
decay-time distribution of a sample of
decays. Our result is fs, where the first uncertainty is statistical and the
second is systematic. This result is significantly more precise than previous
measurements.Comment: 7 pages, 4 figures, to be submitted to Physical Review Letter
Precise Measurement of the D and D Lifetimes at Belle II
We report a measurement of the D and D lifetimes using D→Kπ and D→Kππ decays reconstructed in ee→ data recorded by the Belle II experiment at the SuperKEKB asymmetric-energy ee collider. The data, collected at center-of-mass energies at or near the Υ(4S) resonance, correspond to an integrated luminosity of 72 fb. The results, τ(D)=410.5±1.1(stat)±0.8(syst) fs and τ(D)=1030.4±4.7(stat)±3.1(syst) fs, are the most precise to date and are consistent with previous determinations
Observation of decays using the 2019-2022 Belle II data sample
We present a measurement of the branching fractions of four decay modes. The measurement is based on data from
SuperKEKB electron-positron collisions at the resonance
collected with the Belle II detector and corresponding to an integrated
luminosity of . The event yields are extracted from fits
to the distributions of the difference between expected and observed meson
energy to separate signal and background, and are efficiency-corrected as a
function of the invariant mass of the system. We find the branching
fractions to be: where the first uncertainty is statistical and
the second systematic. These results include the first observation of
, , and decays and a significant improvement in the precision
of compared to previous measurements
- …
